Should I buy Amcor shares for their 'attractive' dividend yield?

A leading analyst delivers his forecast for Amcor's high-yielding shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The past year's share price retrace, coupled with a big lift in dividends, has seen Amcor PLC (ASX: AMC) shares join the ASX's high-yielding club.

There's not really a club.

But at Tuesday's closing price of $54.38, the S&P/ASX 200 Index (ASX: XJO) global packaging giant trades on an unfranked dividend yield (partly trailing, partly forecast) of 6.8%.

As you may be aware, unlike many ASX 200 dividend stocks, which make twice-yearly payouts, Amcor pays its dividends on a quarterly basis.

And with its acquisition of United States-based packaging company Berry Global completed last year, the past two quarters have seen Amcor ramp up its passive income payments.

In the first two quarters of 2026, Amcor declared two unfranked dividends, totalling $1.84 a share. If you owned shares at market close yesterday, you can expect to receive the Q2 dividend of 91 cents a share on 17 June. Amcor stock is trading ex-dividend today.

Now, with Amcor shares down 22% over the past 12 months, and assuming similar dividend payouts in the next two quarters, is the ASX 200 stock a good buy for passive income?

Woman with $50 notes in her hand thinking, symbolising dividends.

Image source: Getty Images

Should you buy Amcor shares for passive income?

Shaw and Partners' Jed Richards recently ran his slide rule over Amcor shares (courtesy of The Bull).

Commenting on the recent headwinds pressuring the stock, he said, "This packaging giant continues to face pressure from elevated input costs, particularly linked to higher oil and plastic prices, which have impacted margins."

But, citing the company's "attractive dividend yield" and ability to pass on rising costs, Richards believes investors should hold onto their Amcor shares. He noted:

Despite this, the company maintains strong global operations and continues to generate stable cash flow. A weaker share price provides an attractive dividend yield for income investors.

Recent updates indicate increased costs have been passed through to customers. Holding is appropriate given its defensive packaging exposure, but upside will likely depend on managing input costs.

What's the latest from the ASX 200 stock?

Amcor shares closed up 3.9% on 7 May, following the release of the company's March quarter results (Q3 FY 2026).

The company noted that with its Berry Global takeover completed, it realised acquisition synergies of US$77 million during the quarter.

The March quarter saw Amcor deliver net sales of US$5.91 billion, up 77% year on year. And adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of US$892 million surged by 87%.

"Third quarter results were in line with expectations and reflect the resilience of our business as we mark the first anniversary of bringing legacy Amcor and Berry together as One Amcor," Amcor CEO Peter Konieczny said on the day.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Amcor Plc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

An oil worker in front of a pumpjack using a tablet.
Broker Notes

Why Woodside shares just got a big buy call

A leading analyst forecasts more outperformance from Woodside’s surging shares.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

Buy, hold, sell: 4DMedical, Cochlear, Westpac shares

An expert discusses his views on Westpac shares and 2 other popular ASX 200 stocks.

Read more »

Woman in business suit holds both hands out with a question mark above each hand.
Broker Notes

Buy, hold, sell: Ampol, Lendlease, BHP shares

Let's check out some new ratings on 3 ASX 200 shares today.

Read more »